Efficacy of combined CDK9/BET inhibition in preclinical models of MLL-rearranged acute leukemia

Hannah McCalmont, Ka Leung Li, Luke Jones, John Toubia, Sarah C Bray, Debora A Casolari, Chelsea Mayoh, Saumya E Samaraweera, Ian D Lewis, Rab K Prinjha, Nicholas Smithers, Shudong Wang, Richard B Lock, Richard J D'Andrea

Research output: Contribution to journalArticle

LanguageEnglish
Pages296-300
Number of pages5
JournalBlood Advances
Volume4
Issue number2
DOIs
Publication statusPublished - 28 Jan 2020
Externally publishedYes

Keywords

  • Leukemia
  • AML
  • Cdk
  • Leukaemia

Cite this

McCalmont, Hannah ; Li, Ka Leung ; Jones, Luke ; Toubia, John ; Bray, Sarah C ; Casolari, Debora A ; Mayoh, Chelsea ; Samaraweera, Saumya E ; Lewis, Ian D ; Prinjha, Rab K ; Smithers, Nicholas ; Wang, Shudong ; Lock, Richard B ; D'Andrea, Richard J. / Efficacy of combined CDK9/BET inhibition in preclinical models of MLL-rearranged acute leukemia. In: Blood Advances. 2020 ; Vol. 4, No. 2. pp. 296-300.
@article{d75f0052c77e4b119423435a066ca7ec,
title = "Efficacy of combined CDK9/BET inhibition in preclinical models of MLL-rearranged acute leukemia",
keywords = "Leukemia, AML, Cdk, Leukaemia",
author = "Hannah McCalmont and Li, {Ka Leung} and Luke Jones and John Toubia and Bray, {Sarah C} and Casolari, {Debora A} and Chelsea Mayoh and Samaraweera, {Saumya E} and Lewis, {Ian D} and Prinjha, {Rab K} and Nicholas Smithers and Shudong Wang and Lock, {Richard B} and D'Andrea, {Richard J}",
year = "2020",
month = "1",
day = "28",
doi = "10.1182/bloodadvances.2019000586",
language = "English",
volume = "4",
pages = "296--300",
journal = "Blood advances",
issn = "2473-9529",
publisher = "American Society of Hematology",
number = "2",

}

McCalmont, H, Li, KL, Jones, L, Toubia, J, Bray, SC, Casolari, DA, Mayoh, C, Samaraweera, SE, Lewis, ID, Prinjha, RK, Smithers, N, Wang, S, Lock, RB & D'Andrea, RJ 2020, 'Efficacy of combined CDK9/BET inhibition in preclinical models of MLL-rearranged acute leukemia', Blood Advances, vol. 4, no. 2, pp. 296-300. https://doi.org/10.1182/bloodadvances.2019000586

Efficacy of combined CDK9/BET inhibition in preclinical models of MLL-rearranged acute leukemia. / McCalmont, Hannah; Li, Ka Leung; Jones, Luke; Toubia, John; Bray, Sarah C; Casolari, Debora A; Mayoh, Chelsea; Samaraweera, Saumya E; Lewis, Ian D; Prinjha, Rab K; Smithers, Nicholas; Wang, Shudong; Lock, Richard B; D'Andrea, Richard J.

In: Blood Advances, Vol. 4, No. 2, 28.01.2020, p. 296-300.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Efficacy of combined CDK9/BET inhibition in preclinical models of MLL-rearranged acute leukemia

AU - McCalmont, Hannah

AU - Li, Ka Leung

AU - Jones, Luke

AU - Toubia, John

AU - Bray, Sarah C

AU - Casolari, Debora A

AU - Mayoh, Chelsea

AU - Samaraweera, Saumya E

AU - Lewis, Ian D

AU - Prinjha, Rab K

AU - Smithers, Nicholas

AU - Wang, Shudong

AU - Lock, Richard B

AU - D'Andrea, Richard J

PY - 2020/1/28

Y1 - 2020/1/28

KW - Leukemia

KW - AML

KW - Cdk

KW - Leukaemia

U2 - 10.1182/bloodadvances.2019000586

DO - 10.1182/bloodadvances.2019000586

M3 - Article

VL - 4

SP - 296

EP - 300

JO - Blood advances

T2 - Blood advances

JF - Blood advances

SN - 2473-9529

IS - 2

ER -